How to choose appropriate medication for overactive bladder: Findings from the largest integrated clinical trial database analysis of mirabegron studies

Medical treatment of overactive bladder (OAB) includes antimuscarinic agents, beta-3 adrenoceptor agonist (mirabegron), or combination with both drugs. Recently, a meta-analysis reported the integrated clinical trial data from 10 phase 2–4, double-blind, 12-week mirabegron monotherapy studies. The r...

Descripción completa

Detalles Bibliográficos
Autor principal: Kuo, Hann-Chorng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830553/
https://www.ncbi.nlm.nih.gov/pubmed/35233352
http://dx.doi.org/10.4103/tcmj.tcmj_167_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830553/
https://www.ncbi.nlm.nih.gov/pubmed/35233352
http://dx.doi.org/10.4103/tcmj.tcmj_167_20

Ejemplares similares